The National Institute of Allergy and Infectious Diseases (NIAID), the national agency dedicated to better understanding and treating disorders of the immune system, requires fast and easy access to data for things like clinical trials and genomic sequencing that are critical to developing new vaccines and treatments. Its Clinical Genomics Program is one way opened up a world of data to researchers. NIAID CIO Mike Tartakovsky highlighted several of the new technologies he has implemented to better share and protect clinical data and touted the agency’s new Biovisualization Lab that is applying virtual reality technology in biomedical research.